Educational guide
T3 Peptide,Tumstatin (69-88), human Peptide
T3 Peptide,Tumstatin (69-88), human US$853.11 Excluding tax and shipping fees In stock Description About T3 Peptide,Tumstatin (69-88), human T3 Peptide,Tumstatin (69-88), human (Uniprot: Q01955) is a peptide derived from anti-angiogenic fragment of the type IV
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
T3 Peptide,Tumstatin (69-88), human
US$853.11
Excluding tax and shipping fees
In stock
Description
About T3 Peptide,Tumstatin (69-88), human
T3 Peptide,Tumstatin (69-88), human (Uniprot: Q01955) is a peptide derived from anti-angiogenic fragment of the type IV collagen alpha3 chain for cancer-targeting research. The T3 Peptide,Tumstatin (69-88), human peptide, H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18) from JPT is produced under strict quality control and quality management.
T3 Peptide,Tumstatin (69-88), human - Specifications
Peptide sequence: H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18)
Amount: 0.5 mg
Purity: > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Non-RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s Non-RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for T3 Peptide,Tumstatin (69-88), human
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for T3 Peptide,Tumstatin (69-88), human
T3 Peptide-Tumstatin-69-88-human.pdf
Properties
Properties of T3 Peptide,Tumstatin (69-88), human
0.5 mg
Cancer biomarker research
Cancer peptides
Freeze-dried in plastic vial
Human
Tumstatin
>90% (HPLC-MS)
No
Further Information to T3 Peptide,Tumstatin (69-88), human
Values
H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18)
20mer cyclized cancer peptide (C12-C18)